AU2002339423A1 - Organo-phosphorous compounds for activating gamma/delta T cells - Google Patents

Organo-phosphorous compounds for activating gamma/delta T cells

Info

Publication number: AU2002339423A1
Authority: AU; Australia
Prior art keywords: organo; delta; cells; phosphorous compounds; activating gamma
Prior art date: 2001-07-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002339423A

Other versions

AU2002339423B2 (en

AU2002339423C1 (en

Inventor

Boran Altincicek

Mathias Eberl

Martin Hintz

Hassan Jomaa

Ann-Kristin Kollas

Armin Reichenberg

Jochen Wiesner

Oliver Wolf

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bioagency AG

Original Assignee

Bioagency AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-20

Filing date

2002-07-18

Publication date

2003-05-29

2001-07-20 Priority claimed from DE2001134705 external-priority patent/DE10134705A1/en

2001-07-25 Priority claimed from DE2001135395 external-priority patent/DE10135395A1/en

2002-07-18 Application filed by Bioagency AG filed Critical Bioagency AG

2002-07-18 Priority claimed from PCT/EP2002/007986 external-priority patent/WO2003009855A2/en

2003-02-17 Application granted granted Critical

2003-02-17 Publication of AU2002339423C1 publication Critical patent/AU2002339423C1/en

2003-05-29 Publication of AU2002339423A1 publication Critical patent/AU2002339423A1/en

2007-03-15 Publication of AU2002339423B2 publication Critical patent/AU2002339423B2/en

2007-06-15 Priority to AU2007202803A priority Critical patent/AU2007202803B2/en

2022-07-18 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002339423A 2001-07-20 2002-07-18 Organo-phosphorous compounds for activating gamma/delta T cells Ceased AU2002339423B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2007202803A AU2007202803B2 (en)	2001-07-20	2007-06-15	Organo-phosphorous compounds for activating gamma/delta T cells

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE2001134705 DE10134705A1 (en)	2001-07-20	2001-07-20	New acyclic or cyclic organophosphorus compounds, are gamma-delta-T cell activators useful e.g. as medicaments for treating asthma, chronic bronchitis, ulcerative colitis, autoimmune diseases or allergies
DE10134705.7		2001-07-20
DE2001135395 DE10135395A1 (en)	2001-07-25	2001-07-25	New acyclic or cyclic organophosphorus compounds, are gamma-delta-T cell activators useful e.g. as medicaments for treating asthma, chronic bronchitis, ulcerative colitis, autoimmune diseases or allergies
DE10135395.2		2001-07-25
PCT/EP2002/007986 WO2003009855A2 (en)	2001-07-20	2002-07-18	Organo-phosphorous compounds for activating gamma/delta t cells

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2007202803A Division AU2007202803B2 (en)	2001-07-20	2007-06-15	Organo-phosphorous compounds for activating gamma/delta T cells

Publications (3)

Publication Number	Publication Date
AU2002339423C1 AU2002339423C1 (en)	2003-02-17
AU2002339423A1 true AU2002339423A1 (en)	2003-05-29
AU2002339423B2 AU2002339423B2 (en)	2007-03-15

Family

ID=26009714

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002339423A Ceased AU2002339423B2 (en)	2001-07-20	2002-07-18	Organo-phosphorous compounds for activating gamma/delta T cells

Country Status (13)

Country	Link
US (3)	US7399756B2 (en)
EP (1)	EP1408984B1 (en)
JP (1)	JP4607451B2 (en)
KR (1)	KR100906018B1 (en)
CN (1)	CN1533279A (en)
AT (1)	ATE411805T1 (en)
AU (1)	AU2002339423B2 (en)
CA (1)	CA2453817C (en)
DE (1)	DE50212935D1 (en)
DK (1)	DK1408984T3 (en)
ES (1)	ES2315411T3 (en)
PT (1)	PT1408984E (en)
WO (1)	WO2003009855A2 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10201458A1 (en) *	2001-04-11	2002-10-17	Adelbert Bacher	New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
CA2453817C (en) *	2001-07-20	2011-09-20	Bioagency Ag	Organophosphorus compounds for the activation of gamma/delta t-cells
FR2833266B1 (en) *	2001-12-11	2004-10-22	Mayoly Spindler Lab	NOVEL PHOSPHONATE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE AS MODULATORS OF THE ACTIVITY OF TGAMMA9 DELTA2 LYMPHOCYTES
FR2836483B1 (en) *	2002-02-22	2006-09-15	Innate Pharma	METHODS FOR PRODUCING GAMMA DELTA T LYMPHOCYTES
GB0212666D0 (en) *	2002-05-31	2002-07-10	Secr Defence	Immunogenic sequences
DE60233576D1 (en) *	2002-12-02	2009-10-15	Innate Pharma	Interleukin-2 and gamma Delta T cell activator containing compositions and their uses
AU2004233898B2 (en) *	2003-04-25	2010-12-23	Gilead Sciences, Inc.	Antiviral phosphonate analogs
EP1689758A2 (en) *	2003-12-02	2006-08-16	Innate Pharma	New class of gamma delta t cells activators and use thereof
US20100291118A1 (en) *	2003-12-02	2010-11-18	Innate Pharma	Class of Gamma Delta T Cells Activators and Use Thereof
US20070134273A1 (en) *	2004-02-10	2007-06-14	Francois Romagne	Composition and method for the treatment of carcinoma
WO2005102385A1 (en)	2004-04-26	2005-11-03	Innate Pharma	Adjuvant composition and methods for its use
ES2363160T3 (en)	2004-07-27	2011-07-22	Gilead Sciences, Inc.	NUCELOSIDIC PHOSPHONATE CONJUGATES AS ANTI-HIV AGENTS.
WO2006067635A2 (en) *	2004-12-20	2006-06-29	Innate Pharma S.A.	USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT
EP1863572A2 (en) *	2005-03-22	2007-12-12	Innate Pharma	New class of t cells activators and use thereof
GB2443591B (en) *	2005-09-07	2010-04-28	Secr Defence	Adjuvanted vaccine
JP2009511449A (en) *	2005-10-06	2009-03-19	イナート・ファルマ	Phosphorylated antigen salt of organic base and crystallization method thereof
WO2008012538A2 (en)	2006-07-25	2008-01-31	The Secretary Of State For Defence	Live vaccine strains of francisella
EP2083830A1 (en)	2006-11-17	2009-08-05	Innate Pharma	Improved methods of using phosphoantigen for the treatment of cancer
EP2123285A1 (en)	2008-05-21	2009-11-25	INSERM (Institut National de la Santé et de la Recherche Médicale)	Nucleosidic phosphoantigens for use in VGAMMA9DELTA2 T cell-mediated therapy
JP5620376B2 (en)	2008-07-08	2014-11-05	ギリアードサイエンシーズ，インコーポレイテッド	Salts of HIV inhibitor compounds
EP2324040B1 (en)	2008-09-10	2014-01-01	Innate Pharma	Novel polymorphic form of chdmapp, method of preparation thereof, and pharmaceutical composition comprising same
GB0901423D0 (en) *	2009-01-29	2009-03-11	Secr Defence	Treatment
GB0901411D0 (en) *	2009-01-29	2009-03-11	Secr Defence	Treatment
GB0906234D0 (en)	2009-04-14	2009-05-20	Secr Defence	Vaccine
US10814006B2 (en)	2015-07-14	2020-10-27	University Of Iowa Research Foundation	Fluorescent prodrugs
ES2892402T3 (en)	2017-08-01	2022-02-04	Gilead Sciences Inc	Crystal forms of ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl Ethyl)(phenoxy)phosphoryl)-L-alaninate to treat viral infections
CN109651429A (en) *	2017-10-11	2019-04-19	清华大学	The small molecule agonist of 2 T cell of V γ 9V δ of efficient stable
EP3723701B1 (en)	2017-12-11	2025-08-06	The Procter & Gamble Company	Method of making phosphono-phosphate containing compounds
CN111465383A (en)	2017-12-11	2020-07-28	宝洁公司	Oral care compositions comprising polymers containing phosphonate groups and anionic groups
US11046798B2 (en)	2017-12-11	2021-06-29	The Procter & Gamble Company	Phosphono-phosphate containing compounds and polymers
US11198763B2 (en)	2017-12-11	2021-12-14	The Procter & Gamble Company	Oral care compositions comprising phosphono-phosphate and anionic group containing polymers
EP3723867A1 (en)	2017-12-11	2020-10-21	The Procter & Gamble Company	Phosphono-phosphate and anionic group containing polymers
US11046817B2 (en)	2017-12-11	2021-06-29	The Procter & Gamble Company	Compositions comprising multi-valent cations and phosphono-phosphate containing polymers
WO2019182904A1 (en)	2018-03-19	2019-09-26	University Of Iowa Research Foundation	Phosphonamidate butyrophilin ligands
EP3856206A1 (en)	2018-09-27	2021-08-04	Phosphogam, Inc.	Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5639653A (en) *	1993-07-19	1997-06-17	Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy	Method for proliferating Vγ2Vδ2 T cells
FR2715660A1 (en)	1994-01-28	1995-08-04	Centre Nat Rech Scient	Organophosphorus activating compounds of Tgammadelta lymphocytes, process for preparing and / or isolating and / or characterizing these compounds, compositions and pharmaceutical uses.
EP0952834A2 (en) *	1996-05-15	1999-11-03	The University of Sheffield	Isopentenyl pyrophosphate isomerase (ipi) and/or prenyl transferase inhibitors
DE19828450A1 (en)	1998-06-26	1999-12-30	Hassan Jomaa	Use of bisphosphonic acid compounds and autoantigens or allergens
FR2782721B1 (en)	1998-09-01	2000-11-03	Inst Nat Sante Rech Med	NOVEL PHOSPHOHALOHYDRIN COMPOUNDS, MANUFACTURING METHOD AND APPLICATIONS
CA2343919A1 (en) *	1998-09-22	2000-03-30	Hassan Jomaa	Genes of the 1-desoxy-d-xylulose biosynthetic pathway
DE19854310A1 (en)	1998-11-25	2000-06-29	Hassan Jomaa	Use of phosphonoformic acid derivatives for the therapeutic and prophylactic treatment of infections
WO2000043403A1 (en) *	1999-01-21	2000-07-27	Chugai Seiyaku Kabushiki Kaisha	2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
FR2791981B1 (en) *	1999-04-06	2001-07-20	Inst Nat Sante Rech Med	COMPOUNDS SELECTIVELY INHIBITING LYMPHOCYTES TGAMMA9DELTA2, AND APPLICATIONS THEREOF
WO2000072022A1 (en) *	1999-05-21	2000-11-30	Jomaa Pharmaka Gmbh	Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid
WO2001022816A1 (en)	1999-09-30	2001-04-05	National Jewish Medical And Research Center	MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS
DE10027821A1 (en)	2000-06-05	2001-12-06	Adelbert Bacher	New intermediate in isoprenoid biosynthesis, useful in screening for potential herbicides, comprises mutant encoding-enzymes sequences for imparting herbicide resistance
AU9052201A (en)	2000-08-07	2002-02-18	Monsanto Technology Llc	Methyl-d-erythritol phosphate pathway genes
DE10201458A1 (en) *	2001-04-11	2002-10-17	Adelbert Bacher	New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
DE10119905A1 (en)	2001-04-23	2002-10-24	Jomaa Pharmaka Gmbh	Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
CA2453817C (en) *	2001-07-20	2011-09-20	Bioagency Ag	Organophosphorus compounds for the activation of gamma/delta t-cells
WO2003038072A1 (en)	2001-10-31	2003-05-08	Universite Libre De Bruxelles	Generation and use of new types of dendritic cells

2002
- 2002-07-18 CA CA2453817A patent/CA2453817C/en not_active Expired - Fee Related
- 2002-07-18 EP EP02776913A patent/EP1408984B1/en not_active Expired - Lifetime
- 2002-07-18 PT PT02776913T patent/PT1408984E/en unknown
- 2002-07-18 DK DK02776913T patent/DK1408984T3/en active
- 2002-07-18 DE DE50212935T patent/DE50212935D1/en not_active Expired - Lifetime
- 2002-07-18 AT AT02776913T patent/ATE411805T1/en active
- 2002-07-18 AU AU2002339423A patent/AU2002339423B2/en not_active Ceased
- 2002-07-18 CN CNA028145585A patent/CN1533279A/en active Pending
- 2002-07-18 US US10/484,143 patent/US7399756B2/en not_active Expired - Fee Related
- 2002-07-18 KR KR1020047000770A patent/KR100906018B1/en not_active Expired - Fee Related
- 2002-07-18 ES ES02776913T patent/ES2315411T3/en not_active Expired - Lifetime
- 2002-07-18 JP JP2003515247A patent/JP4607451B2/en not_active Expired - Fee Related
- 2002-07-18 WO PCT/EP2002/007986 patent/WO2003009855A2/en not_active Ceased
2008
- 2008-06-11 US US12/137,241 patent/US7871992B2/en not_active Expired - Fee Related
2011
- 2011-01-17 US US13/007,852 patent/US20110112054A1/en not_active Abandoned

Publication	Publication Date	Title
AU2002339423A1 (en)	2003-05-29	Organo-phosphorous compounds for activating gamma/delta T cells
AU2003266949A1 (en)	2004-01-19	Compounds
AU2003221098A1 (en)	2003-10-08	Oligofluorenylene compounds
AU2003292429A1 (en)	2004-07-14	Pyrazole compounds
AU2002349297A1 (en)	2003-06-17	Statin-like compounds
AU2003287178A1 (en)	2004-05-04	Chemical compounds
AU2003279366A1 (en)	2004-06-07	Novel compounds
AU2003227234A1 (en)	2003-10-08	Cassette
AU2003287979A1 (en)	2004-05-25	Phenyl compounds
AU2003211385A1 (en)	2003-09-09	Azole compounds
AU2003290661A1 (en)	2004-06-03	Chemical compounds
AU2003211586A1 (en)	2003-09-22	Drugs containing riboflavin-type compounds
AU2003227233A1 (en)	2003-10-08	Cassette
AU2002350381A1 (en)	2003-11-11	Fungicidal composition containing pqds
AU2003216859A1 (en)	2003-10-08	Amidoacetonitrile compounds
AU2003215635A1 (en)	2003-10-13	Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003284217A1 (en)	2004-05-04	Chemical compounds
AU2003280578A1 (en)	2004-05-25	Heterocyclic compounds
AU2003302624A1 (en)	2004-06-23	Silicon compounds
AU2003238896A1 (en)	2003-12-22	Stabilized pharmaceutical compositions containing benzimidazole compounds
AU2003292667A1 (en)	2004-07-22	Benzocycloheptapyridine compounds
AU2003251259A1 (en)	2004-02-09	Novel compounds
AUPR920301A0 (en)	2001-12-20	Neurologically-active compounds
AU2003255322A1 (en)	2004-02-23	Compounds
AU2003275480A1 (en)	2004-05-04	Compounds